Altre lingue Bio Plus Co., Ltd

Azioni

A099430

KR7099430001

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 26/06/2024			Variaz. 5gg	Var. 1 gen.
5.520 ^KRW	+4,15%		+9,09%	-19,65%

10/06	Bio Plus Co., Ltd (KOSDAQ:A099430) annuncia un riacquisto di azioni per un valore di 5.000 milioni di KRW.	CI
10/06	Bio Plus Co., Ltd autorizza un Piano di riacquisto.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Bio Plus Co., Ltd announces an Equity Buyback for KRW 5,000 million worth of its shares.	10/06
Bio Plus Co., Ltd authorizes a Buyback Plan.	10/06
Elevance Health Offers Stronger-Than-Expected 2024 Earnings Outlook After Fourth-Quarter Beat	24/01
Elevance Health Issues Upbeat 2024 Adjusted. Earnings Outlook After 4Q Revenue Gains	24/01
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	09/11
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	09/11
BioPlus Co., Ltd.'s Equity Buyback announced on May 9, 2023, has expired with 743,436 shares, representing 1.28% for ¥4,990.07 million.	08/11
Elevance Health Lifts Full-Year Earnings Outlook as Third-Quarter Results Rise	18/10/23
Elevance Health 3Q Revenue Rises on Higher Premiums	18/10/23
BioPlus Acquisition, Avertix Medical Terminate Business Combination Deal	04/10/23
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	09/08/23
BioPlus Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.	09/05/23
BioPlus Co., Ltd. authorizes a Buyback Plan.	09/05/23
BioPlus Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23
Elevance Health to Acquire Specialty Pharmacy BioPlus for Undisclosed Sum	09/11/22
BioPlus to Raise $14.2 Million from Share Sale; Shares Jump 4%	06/10/22
BioPlus Co., Ltd. announced that it expects to receive KRW 19.99996275 billion in funding	06/10/22
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on December 7, 2021.	08/06/22
BioPlus Co., Ltd.'s Equity Buyback announced on December 7, 2021, has expired with 199,320 shares, representing 1.43% for KRW 4,987.71 million.	07/06/22
BioPlus Co., Ltd.'s Equity Buyback announced on October 13, 2021, has expired.	13/04/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Bio Plus Co., Ltd

Azioni

A099430

KR7099430001

Altre lingue

Filtri